Pharma & Biopharma: Research-Pricing for GMP-Adjacent Quality
Biomiga supports pharma and biopharma R&D programs with two complementary capabilities: a manufactured reagent portfolio anchored by endotoxin-free plasmid DNA, and a custom services group covering gene synthesis, protein expression, cell line development, lentivirus packaging, and next-generation sequencing.
Endotoxin-Free Plasmid DNA at Every Scale
Transfection-sensitive applications — from antibody production to vector manufacturing — depend on plasmid DNA with low endotoxin and consistent quality. Biomiga’s EndoFree line covers the full range:
- Plasmid Miniprep Kit
- Plasmid Midiprep Kit
- Plasmid Maxiprep Kit
- Plasmid Megaprep — For high-yield transfection-grade DNA
- EndoFree ezFlow and EndoFree Plasmid Isolation
- 96-well Plasmid Miniprep for screening campaigns
- High-Capacity Vectors
Contract Services for Discovery and Process Development
When the right answer is “outsource it,” Biomiga’s services group provides:
- Gene synthesis and gene cloning
- Site-directed mutagenesis and mutation detection
- Cell line development
- Protein expression (bacterial, insect, mammalian)
- Lentivirus packaging for transduction studies
- Next-generation sequencing — Illumina HiSeq 2500 and MiSeq capacity
- Library construction for biological samples
See Services for the full scope.
Why Pharma R&D Teams Work with Biomiga
- FDA-registered facility, ISO 9001:2015 certified — quality systems compatible with regulated R&D
- US-manufactured — supply chain transparency and regulatory clarity
- Custom-build capability — kits and services tailored to your protocol
- Competitive pricing — research economics without sacrificing the quality standards your downstream applications need
Talk to Our Pharma Services Team
If you have a recurring reagent need, a custom service project, or a vendor consolidation effort underway, contact us to discuss.